Wednesday, August 26, 2026

ON Semiconductor Guides AI Data Center Revenue to Double in 2026, Sparking 60% Stock Surge

ON Semiconductor projected its AI data center revenue will double year-over-year in 2026 following a Q1 earnings beat. The stock climbed 60.1% over three months on the guidance. The signal points to widening outperformance for AI-focused chip names versus the broader semiconductor sector.

LM Salvado
LM Salvado

May 20, 2026

ON Semiconductor Guides AI Data Center Revenue to Double in 2026, Sparking 60% Stock Surge
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

ON Semiconductor guided its AI data center revenue to double year-over-year in 2026, a forecast that sent the stock up 60.1% over the three months following its Q1 earnings beat.1

The guidance is one of the clearest demand signals yet from the chip supply chain. AI infrastructure buildout is accelerating, and component suppliers with direct data center exposure are pulling ahead of general semiconductor peers.

ON Semi's positioning matters. The company supplies power management and sensing chips used in AI server infrastructure. A revenue doubling projection in that segment reflects not just current orders but committed purchasing pipelines from hyperscalers.1

For traders, the divergence thesis is straightforward: AI-specific semiconductor exposure is outperforming the broader chip index. The test is whether AI data center segments at companies like ON Semi and Nvidia outpace the general semiconductor sector by more than 20% on revenue growth through Q3 2026.1

Macro conditions complicate the picture. The 10-Year US Treasury benchmark moved from 4.31 to 5, signaling tighter financial conditions.1 Rising rates typically compress valuations across growth equities. The exception has been high-growth AI names, where earnings acceleration has overridden multiple compression.

Convertible debt markets are also shifting. ON Semi's 2.50% Convertible Senior Notes saw a notable parameter drop, suggesting restructuring activity in AI-adjacent balance sheets.1 Companies are repositioning capital structures ahead of what they expect to be a sustained growth cycle.

The broader read for semiconductor investors: earnings guidance from AI-adjacent suppliers is now a leading indicator for the sector. When a company with direct hyperscaler exposure doubles its AI revenue forecast, the signal carries weight for the entire supply chain — from power delivery to advanced packaging to memory.

Q2 and Q3 results will test whether the guidance holds. If AI data center revenue tracks the doubling trajectory, expect further rotation into AI-specific chip names and continued underperformance from commodity semiconductor exposure.

In this story · Knowledge Files

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com